Finance

Beta
Lists
MDWD:NASDAQ
Mediwound Ltd
$14.70
-2.52%
(-0.38) 1D
$14.70
0.00% (0.00)
After hours
Closed: Jun 30, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MDWD...
Open
$15.14
High
$15.38
Low
$14.51
Mkt. cap
188.93M
Avg. vol.
107.20K
Volume
37.11K
52-wk high
$21.26
52-wk low
$13.54
EPS
-$2.26
Beta
0.16
Shares outstanding
12.85M
No. of employees
121
Open
$15.14
High
$15.38
Low
$14.51
Mkt. cap
188.93M
Avg. vol.
107.20K
Volume
37.11K
52-wk high
$21.26
52-wk low
$13.54
EPS
-$2.26
Beta
0.16
Shares outstanding
12.85M
No. of employees
121
News stories
From sources across the web
About Mediwound Ltd
CEOOfer Gonen
Employees121
Founded2000
Headquarters-
SectorPharmaceutical industry
Websitemediwound.com
Analyst ratings
Based on 6 analysts giving stock ratings to MDWD in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for MDWD in the last 3 months.
Highest
Current $14.70
$36.00 (+144.90%)
Average
$29.00 (+97.28%)
Lowest
$22.00 (+49.66%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Okunewitch
Maxim Group
Buy
Maintained
$30.00
+104.1%
06/01/2026
Scott Henry
Alliance Global Partners
Buy
Maintained
$22.00
+49.7%
05/28/2026
Jeff Jones
Oppenheimer
Buy
Maintained
$32.00
+117.7%
05/28/2026
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
$36.00
+144.9%
05/28/2026
Josh Jennings
TD Cowen
Buy
Reiterated
$25.00
+70.1%
05/27/2026
Chase Knickerbocker
Craig-Hallum
Buy
Maintained
-
-
04/06/2026
Unknown Analyst
Oppenheimer
Buy
Maintained
$34.00
+131.3%
03/06/2026
Unknown Analyst
Alliance Global Partners
Buy
Maintained
$25.00
+70.1%
03/05/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
5.71M
5.43M
1.87M
1.48M
Cost of goods sold
4.37M
4.53M
1.59M
1.15M
Cost of revenue
4.37M
4.53M
1.59M
1.15M
Research and development expenses
3.49M
3.46M
4.48M
5.18M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.57M
3.96M
3.62M
3.56M
Operating expense
7.06M
7.42M
8.08M
8.30M
Total operating expenses
11.42M
11.95M
9.67M
9.46M
Operating income
-5.72M
-6.52M
-7.80M
-7.98M
Other non operating income
-
-
1.74M
-
EBT including unusual items
-13.28M
-2.60M
-7.11M
-2.97M
EBT excluding unusual items
-13.28M
-2.60M
-7.11M
-2.97M
Income tax expense
38.00K
53.00K
73.00K
-17.00K
Effective tax rate
-0.29%
-2.04%
-1.03%
0.57%
Other operating expenses
-
-
-17.00K
-439.00K
Net income
-13.32M
-2.65M
-7.18M
-2.95M
Net profit margin
-233.32%
-48.85%
-384.73%
-200.14%
Earnings per share
-1.23
-0.24
-0.56
-0.23
Interest and investment income
429.00K
3.93M
993.00K
5.01M
Interest expense
-7.99M
-
-625.00K
-
Net interest expenses
-7.56M
3.93M
368.00K
5.01M
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.32M
-6.11M
-7.55M
-7.60M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer